US2011183885A1PendingUtilityA1

Neo-tryptophan

61
Assignee: MAYO FOUNDATIONPriority: Apr 10, 1998Filed: Mar 31, 2011Published: Jul 28, 2011
Est. expiryApr 10, 2018(expired)· nominal 20-yr term from priority
Inventors:Elliott RichelsonBernadette Marie CusackYuan-Ping PangDaniel J. MccormickAbdul FauqBeth Marie TylerMona Boules
C07K 7/14A61P 25/04A61P 29/00C07K 7/083C07D 209/08C07K 14/702A61K 38/00C07K 14/70C07K 7/18
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77.

Claims

exact text as granted — not AI-modified
1 . A method of inducing antinociception in a human, said method comprising administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. 
     
     
         2 . The method of  claim 1 , wherein the polypeptide is selected from the group consisting of NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, and NT77.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.